Ys Biopharma Co. Ltd (YS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | YS | SCLX | CTOR | ||
| Company | Ys Biopharma Co. Ltd | Scilex Holding Co. | Citius Oncology Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 0.9000 | 11.94 | 1.0500 | ||
| High | 1.1000 | 11.94 | 1.0500 | ||
| Low | 0.9000 | 11.10 | 1.0500 | ||
| Latest | 1.0200 | 11.46 | 1.0500 | ||
| Change | +0.1129 | -0.54 | -0.0300 | ||
| % Change | +12.45% | -4.50% | -2.78% | ||
| Volume | 107,200 | 84,300 | 136 | ||
| 20-Day Average Volume | 81,165 | 77,265 | 477,537 | ||
| Previous Close | 0.9071 | 12.00 | 1.0800 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.8888 | 13.30 | 1.1298 | ||
| 20-Day Raw Stochastic | 79.80% | 7.63% | 20.41% | ||
| 20-Day Relative Strength | 60.44 | 35.63 | 43.07 | ||
| Weighted Alpha | -21.89 | -18.79 | -44.06 | ||
| Today's Opinion | 88% Buy | 40% Sell | 100% Sell | ||
| Previous Opinion | 88% Buy | 40% Sell | 100% Sell | ||
| Last Month's Opinion | 48% Buy | 24% Buy | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.31% since 05/17/24 | -13.77% since 01/08/26 | -3.67% since 01/09/26 | ||
| Low | 0.8810 on 05/22/24 | 11.10 on 01/15/26 | 1.0400 on 01/12/26 | ||
| High | 1.1000 on 05/24/24 | 13.83 on 01/12/26 | 1.1600 on 01/14/26 | ||
| 1-Month | |||||
| %Chg | +25.93% since 04/24/24 | -30.63% since 12/15/25 | -1.87% since 12/16/25 | ||
| Low | 0.7040 on 04/30/24 | 11.10 on 01/15/26 | 0.9500 on 12/31/25 | ||
| High | 1.1000 on 05/24/24 | 16.56 on 12/16/25 | 1.4400 on 12/19/25 | ||
| 3-Month | |||||
| %Chg | +158.29% since 02/23/24 | -20.03% since 10/15/25 | -41.34% since 10/16/25 | ||
| Low | 0.3800 on 03/01/24 | 11.10 on 01/15/26 | 0.9384 on 12/09/25 | ||
| High | 1.1000 on 05/24/24 | 27.00 on 11/21/25 | 1.9500 on 10/20/25 | ||
| 6-Month | |||||
| %Chg | +63.51% since 11/24/23 | +70.28% since 07/15/25 | -33.12% since 07/16/25 | ||
| Low | 0.3503 on 02/02/24 | 6.73 on 07/16/25 | 0.9384 on 12/09/25 | ||
| High | 1.1000 on 05/24/24 | 34.27 on 09/23/25 | 2.8400 on 07/23/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 94,919 | 97,310 | 91,582 | ||
| Shares Outstanding, K | 93,058 | 8,491 | 84,798 | ||
| Annual Sales | 100,000,000 | 56,590,000 | 0 | ||
| Annual Net Income | -21,170,000 | -72,810,000 | -24,760,000 | ||
| Last Quarter Sales | 13,640,000 | 10,560,000 | 0 | ||
| Last Quarter Net Income | -14,680,000 | -257,230,000 | -5,000,000 | ||
| 60-Month Beta | 0.51 | 1.36 | 3.09 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.12 on 04/19/24 | -22.17 on 11/14/25 | -0.06 on 12/23/25 | ||
| Latest Earnings Date | 04/19/24 | 02/13/26 | 02/13/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||